Sterling Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.8K | Buy |
2,870
+1,045
| +57% | +$34.5K | ﹤0.01% | 1365 |
|
|
2025
Q1 | $73.3K | Sell |
1,825
-1,507
| -45% | -$60.6K | ﹤0.01% | 1349 |
|
|
2024
Q4 | $157K | Buy |
3,332
+2,964
| +805% | +$139K | ﹤0.01% | 1331 |
|
|
2024
Q3 | $19.4K | Buy |
+368
| New | +$19.4K | ﹤0.01% | 1481 |
|
|
2017
Q3 | – | Sell |
-52,388
| Closed | -$634K | – | 925 |
|
|
2017
Q2 | $634K | Buy |
+52,388
| New | +$634K | 0.01% | 748 |
|